The safety and efficacy of durvalumab in combination with paclitaxel for the treatment of metastatic triple negative breast cancer

The safety and efficacy of durvalumab in combination with paclitaxel for the treatment of metastatic triple negative breast cancer

Gespeichert in:
Bibliographische Detailangaben
Veröffentlicht in:Annals of oncology 2018-10, Vol.29, p.viii438-viii438
Hauptverfasser: Ghebeh, H., Alsayed, A.N., Suleman, K., Al-Tweigeri, T.
Format: Artikel
Sprache:eng
Online-Zugang:Volltext
Tags: Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
container_end_page viii438
container_issue
container_start_page viii438
container_title Annals of oncology
container_volume 29
creator Ghebeh, H.
Alsayed, A.N.
Suleman, K.
Al-Tweigeri, T.
description
doi_str_mv 10.1093/annonc/mdy288.107
format Article
fullrecord <record><control><sourceid>pubmed_cross</sourceid><recordid>TN_cdi_crossref_primary_10_1093_annonc_mdy288_107</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><els_id>S0923753419496919</els_id><sourcerecordid>32137116</sourcerecordid><originalsourceid>FETCH-LOGICAL-c2787-5c4478eadd427cdc1698faa6c4999e155eb829bf43ba3b5f26666466c705b3373</originalsourceid><addsrcrecordid>eNp9kEFv1DAQhS0EokvLD-CC_AdC7TiJY3FCFQWkSlzKORqPx61R4qxs78Je-8vrVYAjc7Hm6X1P48fYOyk-SGHUNcS4Rrxe3KkdxyrpF2wn-8E0o-jkS7YTplWN7lV3wd7k_FMIMZjWvGYXqpVKSzns2NP9I_EMnsqJQ3ScvA8IeOKr5-6QjjAfFrA8RI7rYkOEEtbIf4XyyPeAcyjwm2bu18RLDSqJoCwUyxlfqEAuFcCqh_1MPNJDXY_EbfXlwhEiUrpirzzMmd7-eS_Zj9vP9zdfm7vvX77dfLprsNWjbnrsOj0SONe1Gh3KwYweYMDOGEOy78mOrbG-UxaU7X071OmGAbXorVJaXTK55WJac07kp30KC6TTJMV07nPa-py2Pqt0Zt5vzP5gF3L_iL8FVsPHzUD18mOgNGUMVL_lQiIsk1vDf-KfASuni2Q</addsrcrecordid><sourcetype>Aggregation Database</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype></control><display><type>article</type><title>The safety and efficacy of durvalumab in combination with paclitaxel for the treatment of metastatic triple negative breast cancer</title><source>Alma/SFX Local Collection</source><source>EZB Electronic Journals Library</source><creator>Ghebeh, H. ; Alsayed, A.N. ; Suleman, K. ; Al-Tweigeri, T.</creator><creatorcontrib>Ghebeh, H. ; Alsayed, A.N. ; Suleman, K. ; Al-Tweigeri, T.</creatorcontrib><identifier>ISSN: 0923-7534</identifier><identifier>EISSN: 1569-8041</identifier><identifier>DOI: 10.1093/annonc/mdy288.107</identifier><identifier>PMID: 32137116</identifier><language>eng</language><publisher>England: Elsevier Ltd</publisher><ispartof>Annals of oncology, 2018-10, Vol.29, p.viii438-viii438</ispartof><rights>2018 THE AUTHORS</rights><lds50>peer_reviewed</lds50><oa>free_for_read</oa><woscitedreferencessubscribed>false</woscitedreferencessubscribed><citedby>FETCH-LOGICAL-c2787-5c4478eadd427cdc1698faa6c4999e155eb829bf43ba3b5f26666466c705b3373</citedby></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><link.rule.ids>314,776,780,27901,27902</link.rule.ids><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/32137116$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink></links><search><creatorcontrib>Ghebeh, H.</creatorcontrib><creatorcontrib>Alsayed, A.N.</creatorcontrib><creatorcontrib>Suleman, K.</creatorcontrib><creatorcontrib>Al-Tweigeri, T.</creatorcontrib><title>The safety and efficacy of durvalumab in combination with paclitaxel for the treatment of metastatic triple negative breast cancer</title><title>Annals of oncology</title><addtitle>Ann Oncol</addtitle><issn>0923-7534</issn><issn>1569-8041</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2018</creationdate><recordtype>article</recordtype><recordid>eNp9kEFv1DAQhS0EokvLD-CC_AdC7TiJY3FCFQWkSlzKORqPx61R4qxs78Je-8vrVYAjc7Hm6X1P48fYOyk-SGHUNcS4Rrxe3KkdxyrpF2wn-8E0o-jkS7YTplWN7lV3wd7k_FMIMZjWvGYXqpVKSzns2NP9I_EMnsqJQ3ScvA8IeOKr5-6QjjAfFrA8RI7rYkOEEtbIf4XyyPeAcyjwm2bu18RLDSqJoCwUyxlfqEAuFcCqh_1MPNJDXY_EbfXlwhEiUrpirzzMmd7-eS_Zj9vP9zdfm7vvX77dfLprsNWjbnrsOj0SONe1Gh3KwYweYMDOGEOy78mOrbG-UxaU7X071OmGAbXorVJaXTK55WJac07kp30KC6TTJMV07nPa-py2Pqt0Zt5vzP5gF3L_iL8FVsPHzUD18mOgNGUMVL_lQiIsk1vDf-KfASuni2Q</recordid><startdate>201810</startdate><enddate>201810</enddate><creator>Ghebeh, H.</creator><creator>Alsayed, A.N.</creator><creator>Suleman, K.</creator><creator>Al-Tweigeri, T.</creator><general>Elsevier Ltd</general><scope>6I.</scope><scope>AAFTH</scope><scope>NPM</scope><scope>AAYXX</scope><scope>CITATION</scope></search><sort><creationdate>201810</creationdate><title>The safety and efficacy of durvalumab in combination with paclitaxel for the treatment of metastatic triple negative breast cancer</title><author>Ghebeh, H. ; Alsayed, A.N. ; Suleman, K. ; Al-Tweigeri, T.</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c2787-5c4478eadd427cdc1698faa6c4999e155eb829bf43ba3b5f26666466c705b3373</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2018</creationdate><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Ghebeh, H.</creatorcontrib><creatorcontrib>Alsayed, A.N.</creatorcontrib><creatorcontrib>Suleman, K.</creatorcontrib><creatorcontrib>Al-Tweigeri, T.</creatorcontrib><collection>ScienceDirect Open Access Titles</collection><collection>Elsevier:ScienceDirect:Open Access</collection><collection>PubMed</collection><collection>CrossRef</collection><jtitle>Annals of oncology</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Ghebeh, H.</au><au>Alsayed, A.N.</au><au>Suleman, K.</au><au>Al-Tweigeri, T.</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>The safety and efficacy of durvalumab in combination with paclitaxel for the treatment of metastatic triple negative breast cancer</atitle><jtitle>Annals of oncology</jtitle><addtitle>Ann Oncol</addtitle><date>2018-10</date><risdate>2018</risdate><volume>29</volume><spage>viii438</spage><epage>viii438</epage><pages>viii438-viii438</pages><issn>0923-7534</issn><eissn>1569-8041</eissn><cop>England</cop><pub>Elsevier Ltd</pub><pmid>32137116</pmid><doi>10.1093/annonc/mdy288.107</doi><oa>free_for_read</oa></addata></record>
fulltext fulltext
identifier ISSN: 0923-7534
ispartof Annals of oncology, 2018-10, Vol.29, p.viii438-viii438
issn 0923-7534
1569-8041
language eng
recordid cdi_crossref_primary_10_1093_annonc_mdy288_107
source Alma/SFX Local Collection; EZB Electronic Journals Library
title The safety and efficacy of durvalumab in combination with paclitaxel for the treatment of metastatic triple negative breast cancer
url https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-02-04T16%3A36%3A46IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-pubmed_cross&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=The%20safety%20and%20efficacy%20of%20durvalumab%20in%20combination%20with%20paclitaxel%20for%20the%20treatment%20of%20metastatic%20triple%20negative%20breast%20cancer&rft.jtitle=Annals%20of%20oncology&rft.au=Ghebeh,%20H.&rft.date=2018-10&rft.volume=29&rft.spage=viii438&rft.epage=viii438&rft.pages=viii438-viii438&rft.issn=0923-7534&rft.eissn=1569-8041&rft_id=info:doi/10.1093/annonc/mdy288.107&rft_dat=%3Cpubmed_cross%3E32137116%3C/pubmed_cross%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_id=info:pmid/32137116&rft_els_id=S0923753419496919&rfr_iscdi=true